Cytosorbents develops therapeutic devices used in purifying blood to treat life-threatening diseases.
CytoSorbents Corporation is a publicly-traded, critical care focused therapeutic device company using blood purification to treat life-threatening illnesses. Its purification technology is based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Each polymer bead contains millions of pores and channels that can be modified to remove substances as small as drugs, to substances as large as antibodies.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 14, 2017 | Grant | $719K | 1 | U.S. Army Medical Research & Development Command | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
U.S. Army Medical Research & Development Command | Yes | Grant |